Patients with locally extensive disease (stage I to II bulky) were compared with patients with
advanced disease (stage III to IV); patients with locally advanced disease had better (A)
failure-free survival (FFS; P = .001) and (B) overall survival (OS; P = ...
Gordon L I et al. JCO 2013;31:684-691
©2013 by American Society of Clinical Oncology